In-situ split (ISS) liver resection: New aspects of technique and indication;"in-situ-Split"- (ISS) Leberresektion: Neue Aspekte zu Technik und Indikation

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 139, Issue 2, 2014, Pages 212-219

  Lang, S A ^a   Loss, M ^a   Schlitt, H J ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

hypertrophy; in situ splitting; indication; liver resection in two steps; resectability; technique

Indexed keywords

ADJUVANT THERAPY; CANCER STAGING; HUMAN; HYPERTROPHY; LAPAROSCOPY; LIGATION; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER REGENERATION; LIVER RESECTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PROCEDURES; PROGNOSIS;

HEPATECTOMY; HUMANS; HYPERTROPHY; LAPAROSCOPY; LIGATION; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER REGENERATION; NEOADJUVANT THERAPY; NEOPLASM STAGING; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 84899944988     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0032-1328742     Document Type: Article

References (40)

1. Choi S. B., Kim K. S., Choi J. Y. et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol: 2009; 16 3048 3056
2. de Haas R. J., Wicherts D. A., Andreani P. et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg: 2011; 253 1069 1079
3. Seehofer D., Neuhaus P. [Current status of multimodal therapy for colorectal liver metastases]. Zentralbl Chir: 2011; 136 343 351
4. Guglielmi A., Ruzzenente A., Conci S. et al. How much remnant is enough in liver resection? Dig Surg: 2012; 29 6 17
5. Knoefel W. T., Alexander A., Tustas R. Y. et al. [Stem cell-induced liver regeneration]. Zentralbl Chir: 2013; 138 166 172
6. Tanaka K., Shimada H., Matsuo K. et al. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol: 2007; 33 329 335
7. Lam V. W., Spiro C., Laurence J. M. et al. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann Surg Oncol: 2012; 19 1292 1301
8. Palavecino M., Chun Y. S., Madoff D. C. et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery: 2009; 145 399 405
9. Tanaka K., Shimada H., Matsuo K. et al. Regeneration after two-stage hepatectomy vs. repeat resection for colorectal metastasis recurrence. J Gastrointest Surg: 2007; 11 1154 1161
10. Tsai S., Marques H. P., de Jong M. C. et al. Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford): 2010; 12 262 269
11. van Lienden K. P., van den Esschert J. W., de Graaf W. et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol: 2013; 36 25 34
12. Wicherts D. A., de Haas R. J., Andreani P. et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg: 2010; 97 240 250
13. Schnitzbauer A. A., Lang S. A., Goessmann H. et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg: 2012; 255 405 414
14. de Santibañes E., Clavien P. A. Playing Play-Doh to prevent postoperative liver failure: the ALPPS approach. Ann Surg: 2012; 255 415 417
15. Alvarez F. A., Ardiles V., Sanchez Claria R. et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg: 2013; 17 814 821
16. Cavaness K. M., Doyle M. B., Lin Y. et al. Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis. J Gastrointest Surg: 2013; 17 207 212
17. Hahn O., Dudas I., Pajor P. et al. [ALPPS (Associated Liver Partition and Portal vein ligation for Staged hepatectomy) - faster and more significant liver hypertrophy]. Magy Seb: 2013; 66 21 26
18. Knoefel W. T., Gabor I., Rehders A. et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg: 2013; 100 388 394
19. Li J., Girotti P., Königsrainer I. et al. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg: 2013; 17 956 961
20. Machado M. A., Makdissi F. F., Surjan R. C. ALPPS procedure with the use of pneumoperitoneum. Ann Surg Oncol: 2013; 20 1491 1493
21. Oldhafer K. J., Donati M., Maghsoudi T. et al. Integration of 3D volumetry, portal vein transection and in situ split procedure: a new surgical strategy for inoperable liver metastasis. J Gastrointest Surg: 2012; 16 415 416
22. Sala S., Ardiles V., Ulla M. et al. Our initial experience with ALPPS technique: encouraging results. Updates Surg: 2012; 64 167 172
23. Konopke R., Kersting S., Bergert H. et al. Contrast-enhanced ultrasonography to detect liver metastases: a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis: 2007; 22 201 207
24. Loss M., Schneider J., Uller W. et al. Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvascularization of malignant liver lesions before surgery or radiofrequeny ablation. Clin Hemorheol Microcirc: 2012; 50 65 77
25. Nadalin S., Testa G., Malago M. et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl: 2004; 10 1024 1029
26. Ono Y., Kawachi S., Hayashida T. et al. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery: 2011; 150 154 161
27. Kanzler S., Teufel A., Galle P. R. [Liver function test to predict hepatic failure after liver resection-expensive and without clinical relevance?]. Zentralbl Chir: 2007; 132 267 273
28. Truant S., Oberlin O., Sergent G. et al. Remnant liver volume to body weight ratio > or = 0.5 %: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg: 2007; 204 22 33
29. Tongyoo A., Pomfret E. A., Pomposelli J. J. Accurate estimation of living donor right hemi-liver volume from portal vein diameter measurement and standard liver volume calculation. Am J Transplant: 2012; 12 1229 1239
30. Muhi A., Ichikawa T., Motosugi U. et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging: 2011; 34 326 335
31. Ramos E., Valls C., Martinez L. et al. Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Ann Surg Oncol: 2011; 18 2654 2661
32. Cucchetti A., Ercolani G., Vivarelli M. et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl: 2006; 12 966 971
33. Farges O., Malassagne B., Flejou J. F. et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg: 1999; 229 210 215
34. Kawano Y., Sasaki A., Kai S. et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol: 2008; 15 1670 1676
35. Kishi Y., Zorzi D., Contreras C. M. et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol: 2010; 17 2870 2876
36. Aloia T., Sebagh M., Plasse M. et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol: 2006; 24 4983 4990
37. Vauthey J. N., Pawlik T. M., Ribero D. et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol: 2006; 24 2065 2072
38. Bachellier P., Rosso E., Pessaux P. et al. Risk factors for liver failure and mortality after hepatectomy associated with portal vein resection. Ann Surg: 2011; 253 173 179
39. Lang H., Sotiropoulos G. C., Brokalaki E. I. et al. Left hepatic trisectionectomy for hepatobiliary malignancies. J Am Coll Surg: 2006; 203 311 321
40. van Gulik T. M., Ruys A. T., Busch O. R. et al. Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough? Dig Surg: 2011; 28 141 147